Therefore, we co-stained Ki67 (a cell proliferation marker), CD133 (a cancer stem cell marker), CD4 (representing CD4+ T-cell infiltration), HLA-I (human leukocyte antigen class I molecules), as well as H3.3-K27M (representing tumor cells harboring the H3F3A mutation), with IL13Ra2 in the same slide to further understand the expression pattern or features of IL13Ra2 in different types of BSGs (Figure 1A). The gene discussed is PROM1; the disease is cancer.